Anat Cell Biol.  2011 Sep;44(3):176-185. 10.5115/acb.2011.44.3.176.

Psammomys obesus, a particularly important animal model for the study of the human diabetic nephropathy

• Scherzer P
• Katalan S
• Got G
• Pizov G
• Londono I
• Gal-Moscovici A
• Popovtzer
• Ziv E
• Bendayan M

• KMID: 1447429
• DOI: http://doi.org/10.5115/acb.2011.44.3.176

Abstract

The Psammomys obesus lives in natural desert habitat on low energy (LE) diet, however when maintained in laboratory conditions with high energy (HE) diet it exhibits pathological metabolic changes resembling those of type 2 diabetes. We have evaluated and correlated the histopathology, metabolic and functional renal alterations occurring in the diabetic Psammomys. Renal function determined by measuring glomerular filtration rate (GFR), protein excretion, protein/creatinine ratio and morpho-immunocytochemical evaluations were performed on HE diet diabetic animals and compared to LE diet control animals. The diabetic animals present a 54% increase in GFR after one month of hyperglycemic condition and a decrease of 47% from baseline values after 4 months. Protein excretion in diabetic animals was 5 folds increased after 4 months. Light microscopy showed an increase in glomeruli size in the diabetic Psammomys, and electron microscopy and immunocytochemical quantitative evaluations revealed accumulation of basement membrane material as well as frequent splitting of the glomerular basement membrane. In addition, glycogen-filled Armanni-Ebstein clear cells were found in the distal tubules including the thick ascending limbs of the diabetic animals. These renal complications in the Psammomys, including changes in GFR with massive proteinuria sustained by physiological and histopathological changes, are very similar to the diabetic nephropathy in human. The Psamommys obesus represents therefore a reliable animal model of diabetic nephropathy.

Keyword

Diabetic nephropathies; Psammomys; Glycogen nephrosis

MeSH Terms

Animals
Basement Membrane
Diabetic Nephropathies
Diet
Ecosystem
Evaluation Studies as Topic
Extremities
Gerbillinae
Glomerular Basement Membrane
Glomerular Filtration Rate
Humans
Light
Microscopy
Microscopy, Electron
Models, Animal
Proteinuria

Figure

• 

  Fig. 1 Glomerular filtration rate (GFR) of the control low energy (LE) diet and the diabetic high energy (HE) diet Psammomys after 4, 8, 12, and 16 weeks. Data are presented as means±SE. P<0.005 vs. controls animals.

• 

  Fig. 2 Histology of representative glomeruli from the diabetic (high energy diet) Psammomys at the beginning of the diet (time 0) and at 8 and 16 wk. Glomeruli area gradually increased in 8 and 16 weeks compared to time 0 (×300). Quantitative data appear in Table 3.

• 

  Fig. 3 (A, B) PAS staining of sections of kidneys from control (low energy [LE] diet) and the diabetic (high energy [HE] diet) Psammomys after 16 wk of feeding with the appropriate diet (×200). C, clear cells.

• 

  Fig. 4 Renal distal tubules. Epithelial cells of the control (low energy [LE] diet) (A) and a diabetic (high energy [HE] diet) (B) animals. In (A) the cytoplasm (cyt) appears normal with its different components, while in (B), the clear cell is filled by glycogen (gly) which was extracted during tissue preparation (×15,000). The cell cytoplasm appears clear; m, mitochondria; mv, microvilli; N, nucleus.

• 

  Fig. 5 Electron micrographs of the glomerular wall of a control (low energy diet) (A) and of a diabetic (high energy diet) (B) animals. For the control animal (A) the glomerular wall appears normal with a thin glomerular basement membrane (GBM) between the endothelial cell (End) and the podocyte (P). On the other hand, for the diabetic animal (B), the GBM, shows sites of increase thickness and material deposition (*) as well as sites where the GBM splits in two (long arrows) (×30,000). Small arrows, slit diaphragm. CL, capillary lumen; US, urinary space.

• 

  Fig. 6 (A, B) Immunocytochemical detection of endogenous serum albumin by the protein A- gold technique. Glomerular walls of a control (A) and a diabetic animal (B). The gold particles reveal that serum albumin antigenic sites are present in large amounts over the capillary lumen (CL) and over the glomerular basement membrane (GBM). In the control animals (A), the labeling appears to be mainly on the endothelial side of the basement membrane, and no gold particles are seen in the urinary space (US). Arrow: slit diaphragm. For the diabetic animal (B), the labeling over the GBM appears to be distributed throughout the GBM and we can detect dense labeled areas in the urinary space (arrowheads) (×40,000). P, podocyte; End, endothelial cell. (C) Distribution of serum albumin immunolabeling across the glomerular wall as expressed over ratio values (R). In the control animals the distribution is asymmetrical, demonstrating that most of the albumin is retained on the endothelial side of the glomerular basement membrane. The distribution for the diabetic animals is more uniform across the basement membrane indicating alteration in the passage of albumin across the glomerular wall.

Reference

1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999. 341:1127–1133.

2. Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol. 2005. 16:Suppl 1. S30–S33.

3. Rudberg S, Osterby R. Decreasing glomerular filtration rate: an indicator of more advanced diabetic glomerulopathy in the early course of microalbuminuria in IDDM adolescents? Nephrol Dial Transplant. 1997. 12:1149–1154.

4. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med. 2003. 254:45–66.

5. Breyer MD, Böttinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, Sharma K. AMDCC. Mouse models of diabetic nephropathy. J Am Soc Nephrol. 2005. 16:27–45.

6. Katoh M, Ohmachi Y, Kurosawa Y, Yoneda H, Tanaka N, Narita H. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Eur J Pharmacol. 2000. 398:381–387.

7. Lee SM, Bressler R. Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes. 1981. 30:106–111.

8. Wald H, Scherzer P, Rasch R, Popovtzer MM. Renal tubular Na(+)-K(+)-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol. 1993. 265(1 Pt 1):E96–E101.

9. Weksler-Zangen S, Yagil C, Zangen DH, Ornoy A, Jacob HJ, Yagil Y. The newly inbred cohen diabetic rat: a nonobese normolipidemic genetic model of diet-induced type 2 diabetes expressing sex differences. Diabetes. 2001. 50:2521–2529.

10. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol. 2003. 284:F1138–F1144.

11. Kalman R, Adler JH, Lazarovici G, Bar-On H, Ziv E. The efficiency of sand rat metabolism is responsible for development of obesity and diabetes. J Basic Clin Physiol Pharmacol. 1993. 4:57–68.

12. Swinburn BA, Boyce VL, Bergman RN, Howard BV, Bogardus C. Deterioration in carbohydrate metabolism and lipoprotein changes induced by modern, high fat diet in Pima Indians and Caucasians. J Clin Endocrinol Metab. 1991. 73:156–165.

13. Shafrir E, Ziv E, Kalman R. Nutritionally induced diabetes in desert rodents as models of type 2 diabetes: Acomys cahirinus (spiny mice) and Psammomys obesus (desert gerbil). ILAR J. 2006. 47:212–224.

14. Scherzer P, Nachliel I, Bar-On H, Popovtzer MM, Ziv E. Renal Na-K-ATPase hyperactivity in diabetic Psammomys obesus is related to glomerular hyperfiltration but is insulin-independent. J Endocrinol. 2000. 167:347–354.

15. Silva FG. D'Agati VD, Jennette JC, Silva FG, editors. Diabetic nephropathy. Non-neoplastic Kidney Diseases. 2005. Washington, DC: American Registry of Pathology;457–459.

16. Holck P, Rasch R. Structure and segmental localization of glycogen in the diabetic rat kidney. Diabetes. 1993. 42:891–900.

17. Robbins SL, Tucker AW Jr. The cause of death in diabetes: a report of 307 autopsied cases. N Engl J Med. 1944. 231:865–868.

18. Bendayan M. Colloidal gold post-embedding immunocytochemistry. Prog Histochem Cytochem. 1995. 29:1–159.

19. Bendayan M, Gingras D, Charest P. Distribution of endogenous albumin in the glomerular wall of streptozotocin-induced diabetic rats as revealed by high-resolution immunocytochemistry. Diabetologia. 1986. 29:868–875.

20. Godfrey K. Statistics in practice. Comparing the means of several groups. N Engl J Med. 1985. 313:1450–1456.

21. Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int. 2005. 68:2562–2571.

22. Janssen U, Phillips AO, Floege J. Rodent models of nephropathy associated with type II diabetes. J Nephrol. 1999. 12:159–172.

23. Yagil C, Barak A, Ben-Dor D, Rosenmann E, Bernheim J, Rosner M, Segev Y, Weksler-Zangen S, Raz I, Yagil Y. Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetes. Diabetes. 2005. 54:1487–1496.

24. Lawson ML, Sochett EB, Chait PG, Balfe JW, Daneman D. Effect of puberty on markers of glomerular hypertrophy and hypertension in IDDM. Diabetes. 1996. 45:51–55.

25. Wald H, Popovtzer MM. The effect of streptozotocin-induced diabetes mellitus on urinary excretion of sodium and renal Na+-K+-ATPase activity. Pflugers Arch. 1984. 401:97–100.

26. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol. 2004. 286:F8–F15.

27. Vallon V, Blantz RC, Thomson S. Homeostatic efficiency of tubuloglomerular feedback is reduced in established diabetes mellitus in rats. Am J Physiol. 1995. 269(6 Pt 2):F876–F883.

28. Popovtzer MM. Shafrir E, Renold AE, editors. Tubular glomerular balance in diabetes mellitus. Lessons from animal diabetes. 1984. London/Paris: John Libbey;513–517.

29. Popovtzer MM, Wald H, Scherzer P. Zhang J, Du X, Liu Z, Li H, editors. The diabetic kidney: lesson in the resetting of tubuloglomerular feedback. Proceedings of the 4th Asian-Pacific Congress in Nephrology. 1991. Beijing: International Academic Publishers;379–382.

30. Scherzer P, Popovtzer MM. Segmental localization of mRNAs encoding Na(+)-K(+)-ATPase alpha(1)- and beta(1)-subunits in diabetic rat kidneys using RT-PCR. Am J Physiol Renal Physiol. 2002. 282:F492–F500.

31. Velasquez MT, Michaelis OE, Szallasi T, Abraham AA, Kimmel PL, Bosch JP. Glomerular hypertrophy and mesangial expansion in the SHR/N-cp rat with type II diabetes: role of type of carbohydrate diet. Kidney Int. 1990. 37:523.

32. Vora JP, Zimsen SM, Houghton DC, Anderson S. Evolution of metabolic and renal changes in the ZDF/Drt-fa rat model of type II diabetes. J Am Soc Nephrol. 1996. 7:113–117.

33. Finlayson JS, Asofsky R, Potter M, Runner CC. Major urinary protein complex of normal mice: origin. Science. 1965. 149:981–982.

34. Fukuzawa Y, Watanabe Y, Inaguma D, Hotta N. Evaluation of glomerular lesion and abnormal urinary findings in OLETF rats resulting from a long-term diabetic state. J Lab Clin Med. 1996. 128:568–578.

35. Myers BD, Nelson RG, Williams GW, Bennett PH, Hardy SA, Berg RL, Loon N, Knowler WC, Mitch WE. Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest. 1991. 88:524–530.

36. Andersen S, Blouch K, Bialek J, Deckert M, Parving HH, Myers BD. Glomerular permselectivity in early stages of overt diabetic nephropathy. Kidney Int. 2000. 58:2129–2137.

37. Gall MA, Rossing P, Kofoed-Enevoldsen A, Nielsen FS, Parving HH. Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 1994. 37:195–201.

38. Rasch R. Tubular lesions in streptozotocin-diabetic rats. Diabetologia. 1984. 27:32–37.

39. Rasch R, Gøtzsche O. Regression of glycogen nephrosis in experimental diabetes after pancreatic islet transplantation. APMIS. 1988. 96:749–754.

40. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest. 1998. 102:619–624.

41. Bamri-Ezzine S, Ao ZJ, Londoño I, Gingras D, Bendayan M. Apoptosis of tubular epithelial cells in glycogen nephrosis during diabetes. Lab Invest. 2003. 83:1069–1080.

42. Hennigar RA, Mayfield RK, Harvey JN, Ge ZH, Sens DA. Lectin detection of renal glycogen in rats with short-term streptozotocin-diabetes. Diabetologia. 1987. 30:804–811.

43. Londoño I, Bamri-Ezzine S, Gingras D, Bendayan M. Redistribution of integrins in tubular epithelial cells during diabetic glycogen nephrosis. Nephron Exp Nephrol. 2004. 98:e22–e30.

44. Nannipieri M, Lanfranchi A, Santerini D, Catalano C, Van de Werve G, Ferrannini E. Influence of long-term diabetes on renal glycogen metabolism in the rat. Nephron. 2001. 87:50–57.

45. Tsuchitani M, Kuroda J, Nagatani M, Miura K, Katoh T, Saegusa T, Narama I, Itakura C. Glycogen accumulation in the renal tubular cells of spontaneously occurring diabetic WBN/Kob rats. J Comp Pathol. 1990. 102:179–190.

46. Chen YT, Coleman RA, Scheinman JI, Kolbeck PC, Sidbury JB. Renal disease in type I glycogen storage disease. N Engl J Med. 1988. 318:7–11.

47. Reitsma-Bierens WC, Smit GP, Troelstra JA. Renal function and kidney size in glycogen storage disease type I. Pediatr Nephrol. 1992. 6:236–238.

48. Verani R, Bernstein J. Renal glomerular and tubular abnormalities in glycogen storage disease type I. Arch Pathol Lab Med. 1988. 112:271–274.